Provided by Tiger Trade Technology Pte. Ltd.

Galmed Pharmaceuticals

4.63
+0.805021.05%
Volume:303.32K
Turnover:1.24M
Market Cap:4.82M
PE:- -
High:4.63
Open:3.91
Low:3.82
Close:3.83
52wk High:13.20
52wk Low:3.29
Shares:1.04M
Float Shares:974.73K
Volume Ratio:21.40
T/O Rate:31.12%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-19.1292
ROE:-68.21%
ROA:-30.19%
PB:0.38
PE(LYR):-0.24

Loading ...

Galmed Pharmaceuticals - Colospan Shareholders to Receive $2.5 Mln Cash and $2 Mln in Galmed Shares at Closing

THOMSON REUTERS
·
Jun 08

Galmed Pharmaceuticals - Plans $6 Mln Investment to Launch Colospan Device in Europe During H2 2026

THOMSON REUTERS
·
Jun 08

Galmed Pharmaceuticals to Acquire Colospan to Create a Gi-Focused Platform Targeting a $6 Billion Market

THOMSON REUTERS
·
Jun 08

UK's Mhra: Resmetirom (Rezdiffra) Authorised to Treat Metabolic Dysfunction-Associated Steatohepatitis (Mash) in Adults

THOMSON REUTERS
·
Jun 03

Galmed and Tissue Dynamics’ two-drug combination targets cardiac fibrosis

TIPRANKS
·
Jun 02

Galmed, Tissue Dynamics say Aramchol combo cuts fibrosis about 4-fold in human cardiac organoid study

Reuters
·
Jun 02

Galmed Pharmaceuticals Ltd expected to post a loss of 38 cents a share - Earnings Preview

Reuters
·
May 18

Galmed reports results from first-in-man PK study of Aramchol Meglumine

TIPRANKS
·
May 14

Galmed Announces Results From First-in-Man Pharmacokinetics Study of Oral Formulation of Aramchol Meglumine (Am); 400Mg Am Increases Bioavailability by ~500% in Comparison to Aramchol Free Acid (Aa) 300Mg

THOMSON REUTERS
·
May 14

Galmed Pharmaceuticals Partners with Tissue Dynamics on Human Cardiac Fibrosis Platform

TIPRANKS
·
May 06

Tissue Dynamics and Galmed Pharmaceuticals to Develop Human-Centered Chronic Cardiac Fibrosis Platform to Advance Aramchol-Based Therapeutics

THOMSON REUTERS
·
May 06

Galmed partners Tissue Dynamics to develop chronic cardiac fibrosis organoid platform

Reuters
·
May 06

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Galmed Pharmaceuticals (GLMD), Neurocrine (NBIX) and Mesoblast (MESO)

TIPRANKS
·
Apr 15

BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Nano-X, Travere

Reuters
·
Apr 14

Galmed Pharmaceuticals Teams with Tel Aviv University on Aramchol for Metastatic Brain Cancer

TIPRANKS
·
Apr 14

Galmed partners with Tel Aviv University to test Aramchol in brain metastases

Reuters
·
Apr 14

Galmed Announces a Collaboration Agreement With Tel Aviv University to Evaluate Its Scd1 Inhibitor, Aramchol, as a Targeted Therapy for Metastatic Brain Cancers

THOMSON REUTERS
·
Apr 14

BUZZ-U.S. STOCKS ON THE MOVE-Amazon, Northrop Grumman, Brown-Forman

Reuters
·
Apr 10

Why Is Galmed Pharmaceuticals Stock (GLMD) Up Today?

TIPRANKS
·
Apr 09

BUZZ-Galmed jumps on lab data on new brain-penetrating version of experimental drug

Reuters
·
Apr 09